Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices

Circulation: Heart Failure

Volumn 4, Issue 6, 2011, Pages 779-784

  Suarez, Jorge ^a   Patel, Chetan B ^a   Felker, G Michael ^a   Becker, Richard ^a   Hernandez, Adrian F ^a   Rogers, Joseph G ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Bleeding rates; Gastrointestinal bleeding; Left ventricular assist devices; Thrombosis

Indexed keywords

ACRYLIC ACID; ANTICOAGULANT AGENT; POLITEF; TITANIUM;

ANGIODYSPLASIA; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING TENDENCY; BRAIN HEMORRHAGE; EPISTAXIS; EQUIPMENT DESIGN; GASTROINTESTINAL HEMORRHAGE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MATERIAL COATING; MULTICENTER STUDY (TOPIC); OPERATION DURATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL RISK; THROMBOCYTE DISORDER; THROMBOEMBOLISM; TREATMENT OUTCOME; VON WILLEBRAND DISEASE; CIRCULATION; HEART ASSIST DEVICE; HEART FAILURE; INCIDENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; THROMBOCYTE AGGREGATION;

BLOOD CIRCULATION; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; PLATELET AGGREGATION; RISK FACTORS; VON WILLEBRAND DISEASES;

EID: 84855585557     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.962613     Document Type: Article

References (31)

1. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN III. Chronic mechanical circulatory support for inotropedependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50:741-747. (Pubitemid 47239315)
2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
3. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation. 2010;122:173-183.
4. Daneshmand MA, Rajagopal K, Lima B, Khorram N, Blue LJ, Lodge AJ, Hernandez AF, Rogers JG, Milano CA. Left ventricular assist device destination therapy versus extended criteria cardiac transplant. Ann Thorac Surg. 2010;89:1205-1209.
5. Dembitsky WP, Tector AJ, Park S, Moskowitz AJ, Gelijns AC, Ronan NS, Piccione W Jr, Holman WL, Furukawa S, Weinberg AD, Heatley G, Poirier VL, Damme L, Long JW. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg. 2004;78:2123-2129.
6. Hernandez AF, Shea AM, Milano CA, Rogers JG, Hammill BG, O'Connor CM, Schulman KA, Peterson ED, Curtis LH. Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA. 2008;300:2398-2406.
7. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM III, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361: 2241-2251.
8. John R, Kramdar F, Liao K, Colvin-Adams M, Miller L, Joyce L, Boyle A. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg. 2008;136: 1318-1323.
9. Gregoric ID, Cohn WE, Frazier OH. Diaphragmatic implantation of the HeartWare ventricular assist device. J Heart Lung Transplant. 2011;30: 467-470.
10. Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, Toninato C, Missov E, Pritzker M, Martin C, Garry D, Thomas W, Joyce L. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009; 137:208-215.
11. Geisen U, Heilman C, Beyeresdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg. 2008;33:679-684.
12. Genovese EA, Dew MA, Teuteberg JJ, Simon MA, Kay J, Siegenthaler MP, Bhama JK, Bermudez CA, Lockard KL, Winowich S, Kornos RL. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg. 2009;88: 1162-1170.
13. Stern DR, Kazam J, Edwards P, Maybaum S, Bello RA, D'Alessandro DA, Goldstein FJ. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg. 2010;25: 352-356.
14. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-321.
15. Pal JD, Piacentino V, Cuevas AD, Depp T, Daneshmand MA, Hernandez AF, Felker GM, Lodge AJ, Rogers JG, Milano CA. Impact of left ventricular assist device bridging on posttransplant outcomes. Ann Thorac Surg. 2009;88:1457-1461.
16. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappelman S, Naka Y, Mancini D. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207-1213.
17. Crow S, Chen D, Milano C, Thomas JW, Joyce L, Piacention V III, Sharma R, Wu J, Arepally G, Bowles D, Rogers J, Villamizar-Ortiz N. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90:1263-1269.
18. Jessup ML, Goldstein D, Ascheim DD, Teuteberg JJ, Park SJ, Naftel DC, Gonzales-Stawirski GV, Ulisney KL, Kirklin JK, Kormos RL. Risk for bleeding after MCSD implant: an analysis of 2358 patients in INTERMACS. J Heart Lung Transplant. 2011;30(suppl I):S9.
19. Morgan J, Brewer R, Nemeh H. Gastrointestinal bleeding with the Heartmate II left ventricular assist device. Abstract presented at: American Society of Artificial Internal Organs Annual Conference; June 11, 2011; Washington, DC.
20. Bonde P, Dew MA, Meyer D, Tallaj JJ, Martin T, Hollifield KA, Slaughter M, Starling R, Kormos RL. National trends in readmission (REA) rates following left ventricular assist device (LVAD) therapy. J Heart Lung Transplant. 2011;30(suppl I):S9.
21. Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, Frazier OH, Heatley G, Farrar DJ, John R. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009; 28:881-887.
22. John R, Boyle A, Pagnani F, Miller L. Physiologic and pathologic changes in patients with continuous-flow ventricular assist devices. J Cardiovasc Transl Res. 2009;2:154-158.
23. Zhou Z, Nguyen TC, Guchhait P, Dong JF. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Thromb Hemost. 2010;36:71-81.
24. Vincentelli A, Susen S, LeTourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343-349. (Pubitemid 36886240)
25. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol. 2009;53:2162-2167.
26. Tsai HM, Sussman II, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood. 1994;83:2171-2179. (Pubitemid 24112728)
27. Baldauf C, Schneppenheim R, Stacklies W, Obser T, Pieconka A, Schneppenheim S, Budde U, Zhou J, Grater F. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis. J Thromb Haemost. 2009;7:2096-2105.
28. Crow S, Milano C, Joyce L, Chen D, Arepally G, Bowles D, Thomas W, Ortiz NV. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. ASAIO J. 2010;56:441-445.
29. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005;24:105-109. (Pubitemid 40094003)
30. Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC, Frazier OH. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2011;30:849-853.
31. Bechtel JF, Wellhoner P, Charitos EI, Bucsky B, Morshmis M, Sievers HH. Localizing an occult gastrointestinal bleeding by wireless PillCam SB capsule videoendoscopy in a patient with the HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg. 2010;139:e73-e74.